NeuroCog leverages advanced cognitive testing and monitoring, eye-tracking technology, and artificial intelligence algorithms to enable early and non-invasive detection of cognitive decline.
We can overcome the limitations of existing diagnostic methods and facilitate timely interventions to curb cognitive decline.
What we do
EARLY DETECTION
In the new era of disease-modifying drugs for Alzheimer’s, our comprehensive cognitive assessment plays an indispensable role in early detection, enabling timely initiation of treatment.
CLINICAL DECISION
The AI-powered Clinical Decision Support System partners with doctors to provide personalized treatments, ensuring the best possible outcomes for patients.
What Makes Us Different
ADVANCED MONITORING
The advanced cognitive health monitoring goes beyond the limitations of learning and ceiling effects found in other assessments, providing reliable and repeatable tests that effectively detect even subtle changes in performance.
nON-INVASIVE
The innovative integration of cognitive testing and remote eye-tracking technology taps into the wisdom that “the eyes are windows to the brain,” offering a non-invasive approach to assessing brain functions through the analysis of eye movement patterns.
HIGH SENSITIVITY
The assessments capture even the subtlest changes in cognitive performance, providing a comprehensive understanding of an individual’s cognitive health with remarkable sensitivity.
ARTIFICIAL INTELLIGENCE
The artificial intelligence algorithms extract valuable insights from patterns within cognitive health data, resulting in significantly enhanced assessment accuracy.